Medical Management/Treatment Date Ordered Date Performed Date Changed General Description Indications or Purpose Client's Response To Treatment
Medical Management/Treatment Date Ordered Date Performed Date Changed General Description Indications or Purpose Client's Response To Treatment
IVF: Plain Normal Saline DO: 8-17-8 PNSS is under isotonic Used as a vehicle
Solution 1L x 31-32 gtts/min DP: 8-17-8 solution where they have for administration The patient complied with
8-18-8 the same concentration of drugs. the doctors order.
8-18-8 of solutes (osmolarity as
8-19-8 blood plasma). This
8-20-8 prevents sudden shift of
DC: 8-21-8 fluids & electrolytes in
the body. This solution
contains 154 mEq/L of
Na and Cl. It expands Source of water,
plasma and interstitial electrolytes and
volume and does not calories or as an
enter the cells. alkalinizing agent.
5% Dextrose and
Lactated Ringer’s
5% Dextrose and Lactated Solution is a hypertonic
Ringer’s Solution 1L x 31-32 DO: 8-21-8 infusion raise serum The patient complied with
gtts/min DP: 8-21-8 osmolality by causing a the doctors order and the
8-21-8 pull of fluids from the patient was able to
8-22-8 intracellular and maintain normal hydration
DC: 8-22-8 interstitial compartments status.
into the blood vessels. To prevent
They act to greatly electrolyte
expand the intravascular imbalance and
compartment. Its shows serve as a route for
how red blood cells administration for
shrink when place in a IV medication;
hypertonic solution. absorbs fluid in
the interstitial cell;
Hypertonic solution that replacement of
has osmolarity higher fluid, sodium,
than serum osmolarity, chloride and
D5NM 1L x 31-32 gtts/min when a patient receives a calories
hypertonic IV solution,
serum osmolarity
DO: 8-22-8 initially increasing fluid The patient complied with
DP: 8-22-8 to be pulled from the the doctors order.
8-23-8 interstitial and
8-23-8 intracellular
8-23-8 compartment into the
8-24-8 blood vessels.
8-24-8
8-25-8
Date Terminated:
8-25-8